Got a post pulled for cross promotion but I thought the heading belonged over here. After reading that quarterly I agree with some thoughts over here that they sound a little confident in putting down a short timeline. Personally I take 'early in Q4 2015' to mean all the way up till mid Nov and then I always apply a biotech slippage of a few weeks but suffice to say I am happy with the short sharp quarterly and the ever increasing focus on oncology. Mostly I am glad that the strategy is being led by the success in the science rather than management just picking a direction.
If the news is good we might have a go at the 5c area again (low prob) but should at least settle back in 2-4c land (high prob).
Enjoying my break - a little rusty on the posting when I returned - how embarrasing to have your first post back moderated!
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)